This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Increased awareness of infectious diseases during the pandemic may have improved vaccine uptake among Medicare enrollees, while service reductions and vaccine hesitancy affected Medicaid enrollees.
Fournier, BSc Key Takeaways The 2024-2025 influenza season saw unprecedented severity, with high hospitalization and outpatient visit rates due to a vaccine mismatch and dominant H1N1 and H3N2 strains. Targeted public health strategies are needed to improve vaccine access, education, and trust, particularly in underserved communities.
Updated June 15, 2020. 9 If a situation warrants measurement of DOAC levels, such as a major bleeding event or concern about drug accumulation, the preferred test to quantify the anticoagulant effects would be anti–factor Xa activity calibrated specifically for the DOAC being measured. REFERENCES Rivaroxaban. MedlinePlus. link] Edoxaban.
Data collection spanned January 2020 to March 2023. This study examines herbal supplement prevalence, pharmacist interventions, and their impact on oncology treatment safety. Materials and Methods A survey-based observational study was conducted at the UC Davis Comprehensive Cancer Center.
2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.
Insani WN, Qonita NA, Jannah SS, et al. Improper disposal practice of unused and expired pharmaceutical products in Indonesian households. 2020;6(7):e04551. doi:10.1016/j.heliyon.2020.e04551 What to do with unwanted household medicines. United States Environmental Protection Agency. Updated March 28, 2025. Accessed June 6, 2025. Take Back Day.
Signal Transduction Targeted Therapy 2020; 5:101. HALO: results from a phase 2 double-blind, placebo-controlled trail evaluating the efficacy and safety of baxdrostat in patients with uncontrolled hypertension. Presented at ACC/WCC 2023. March 4, 2023. New Orleans. Hu B, Zhong L, Weng Y, et al. Therapeutic siRNA: state of the art.
The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion. A long-time leader in vaccines, the U.K. While Enhertu pulled in about $3.8 billion last year , Datroway is expected to hit about $33 million in sales this year.
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9.
trillion economic impact in 2020. trillion economic impact in 2020. trillion (about $4600 per capita in the US) in 2020. trillion in 2020. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk. It just might start saving lives. REFERENCES 1.
While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. 1991;68(3):499-501. doi:10.1002/1097-0142(19910801)68:3 3.0.co;2-f European Medicines Agency. Accessed July 21, 2025. link] NHS England.
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. September 13, 2020. Trump to pitch sweeping Medicare drug price plan. May 7, 2025. Accessed May 13, 2025.
On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges.
Episode 8: Stay in Sync with Innovations in Medication Decision Support Drug Topics staff August 6th 2020 Podcast Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
The investigators conducted a retrospective study and gathered patient information from the hospital information system of Shenzhen Luohu People’s Hospital from May 1, 2020, to December 31, 2023. The primary study end point was the Humira retention rate at week 52, which was estimated through survival analysis. 0.92) and 0.44 (95% CI 0.34–0.52),
Since launching Amazon Pharmacy in November of 2020, we've made it easier for patients to access low-priced medications and have them delivered to their door. Common barriers that I think of include access and cost, but also treatment complexity and forgetfulness. Subscribe Now!
1 Interestingly, there were similar rates of biosimilar initiation by age group every year except for 2020 ( p =.03), 03), which the authors deduced was likely because of the small number of patients initiating anti-TNFs in the under 6 years age group (n = 17) in 2020. 1 About 17.3%
Prior to this, he began his career at Innovent Biologics in 2020 as a cell culture researcher and supervisor, responsible for leading the development of upstream process and Innovents proprietary IP in-house media. Dr Shi holds a doctorates degree in mechanobiology from the National University ofSingapore.
Episode 8: Stay in Sync with Innovations in Medication Decision Support Drug Topics staff August 6th 2020 Podcast Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
Updated January 22, 2020. months versus 7.79 months with tislelizumab. A study of TQB2450 or placebo combined with anlotinib, etoposide and carboplatin versus etoposide and carboplatin in subjects with extensive small cell lung cancer (ETER701). Accessed June 25, 2025.
In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.
Using data from the National Cancer Database, they performed a retrospective analysis on patients diagnosed with metastatic HR–/HER2+ breast cancer between January 2013 and December 2020. 031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). 3 Among the patients, approximately 75.8%
Updated May 6, 2020. link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.
How will RFK Jr’s American dream for vaccines play out? In a move towards transparency, the US Food and Drug Administration (FDA) has published more than 200 archived complete response letters (CRLs), which detail reasons for non-approval of drug applications submitted between 2020 and 2024.
Episode 8: Stay in Sync with Innovations in Medication Decision Support Drug Topics staff August 6th 2020 Podcast Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
It is important to note that, for the purpose of subcutaneous biologics market analysis, the biologics were segregated into antibodies , nucleotides, proteins and vaccines. As can be observed in the figure, the highest number of subcutaneous biologics were approved between 2011 and 2020.
In the summer of 2020, in the aftermath of a deadly and mysterious outbreak of a mosquito-borne disease, two prestigious universities forged a dream partnership. Continue to STAT+ to read the full story…
PCMA unanimous Supreme Court decision in 2020, which allowed states to regulate PBMs, the big health insurance companies and their PBM lobby have been barnstorming the country putting up one legal challenge after another. Douglas Hoey on the U.S.
How will RFK Jr’s American dream for vaccines play out? Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed.
Founded in 2020, Scorpion raised $420m in the next five years while partnering with several pharmaceutical firms and producing six development candidates, three of which are now undergoing clinical trials.
How will RFK Jr’s American dream for vaccines play out? Blenrep originally won FDA approval in 2020 to treat multiple myeloma. The drugmaker is also seeking a positive decision for the antibody-drug conjugate (ADC) used in combo with Bristol Myers Squibb’s Pomalyst and dexamethasone in the same proposed patient group.
How will RFK Jr’s American dream for vaccines play out? Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData.
Following a 2020 agreement, Biogen has the exclusive licence to develop and commercialise Zurzuvae outside the US, excluding Japan, Taiwan, and South Korea. The acquisition affords Supernus a dominant position in the market. Co-developed with Biogen, Zurzuvae earned Sage $36.1m in sales in 2024 and $13.8m in Q1 2025.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Licensing deals between US and Chinese biopharma companies hit record highs last year, up 280% from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates.
image credit: Drobot Dean / stock.adobe.com READ MORE: ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Along with older adults over 65, children too are deemed at risk of contracting respiratory illnesses; a risk that was significantly increased during the COVID-19 pandemic.
How will RFK Jr’s American dream for vaccines play out? This growth is projected to continue, with GlobalData estimating the market will achieve a value of $40bn by 2020. Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. In 2011, the market was worth an estimated $50m.
How will RFK Jr’s American dream for vaccines play out? By GlobalData Learn more about Strategic Intelligence Blenrep was approved under the FDA accelerated approval process in 2020 to treat multiple myeloma (MM). Stay proactive with real-time data and expert analysis.
Recent Videos Related Content COVID-19 Hospitalizations Disproportionately Impacted Black, Hispanic Children Brian Nowosielski July 16th 2025 Article Researchers characterized trends in COVID-19 hospitalizations by race and ethnicity among children from March 2020 to September 2023.
1 The researchers’ findings highlight a need for increasing equitable access to therapies and vaccines for COVID-19. 1 The researchers’ findings highlight a need for increasing equitable access to therapies and vaccines for COVID-19. 4 It wasn’t until late in 2021 when younger children began receiving approval for COVID-19 vaccines.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content